Latest News and Press Releases

MECHELEN, Belgium, Nov. 24, 2005 (PRIMEZONE) -- Galapagos NV (Euronext:GLPG) (LSE:GLPG) announced today that it has entered into a collaboration with Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) on...

-- Acquisition of BioFocus completed, integration progresses as planned -- Galapagos year to date revenues 8% below last year's revenues, but cash burn in line with forecast --...

MECHELEN, Belgium, Nov. 9, 2005 (PRIMEZONE) -- Galapagos (Euronext:GLPG) (LSE:GLPG), a genomics-based drug discovery company, has appointed David R. Smith as Chief Financial Officer to Galapagos per...

MECHELEN, Belgium, Nov. 2, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company (Euronext Brussels, GLPG; Euronext Amsterdam, GLPGA, London AiM: GLPG) announced today that it...

MECHELEN, Belgium, Oct. 18, 2005 (PRIMEZONE) -- Galapagos (Euronext Brussels: GLPG) (Euronext Amsterdam: GLPGA) announced today that its services division BioFocus has reached agreement with the...

MECHELEN, Belgium, Oct. 14, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company, announces that an article presenting the Company's approach to target discovery will appear in...

MECHELEN, Belgium, Oct. 13, 2005 (PRIMEZONE) -- Galapagos (Euronext Brussels: GLPG) (Euronext Amsterdam - GLPGA) announces that on October 12, valid acceptances had been received for 12,552,464...

MECHELEN, Belgium and LEIDEN, Netherlands, Oct. 7, 2005 (PRIMEZONE) -- Galapagos (Euronext Amsterdam:GLPGA) (Euronext Brussels:GLPG), today announced that it received a Notice of Allowance of a third...

MECHELEN, Belgium and LEIDEN, Netherlands Oct. 3, 2005 (PRIMEZONE) -- Galapagos NV (Euronext Amsterdam: GLPGA, Euronext Brussels: GLPG), invites investors, the media and the general public to view a...

LEIDEN and AMSTERDAM, Netherlands, Sept. 14, 2005 (PRIMEZONE) -- Galapagos, Amsterdam Molecular Therapeutics B.V. (AMT), the Netherlands Institute for Brain Research (NIBR), and the Vrije...